Featured Insights

31. 5 Questions On Exploring Healthcare Decision-Maker Sentiments 4/14/2025

    Research presented at AMCP 2025 uses natural language processing on decision-maker feedback to predict coverage. Learn about the surprising findings and next steps in this Q&A.

32. Scientific Literature Reviews And AI's Potential For Evidence Synthesis 4/14/2025

    Scientific literature reviews are crucial for HEOR decision-making but notoriously slow. Explore how AI can potentially accelerate evidence synthesis while maintaining necessary scientific rigor.

33. Key Takeaways From The ISPE Aseptic Processing Seminar 4/14/2025

    How is the pharmaceutical industry increasing aseptic processing safety? An ISPE event showcased innovations like robotics and improved risk management, aligning with recent regulatory guidance.

34. Essential Guide To Post-Approval Regulatory Lifecycle Maintenance 4/14/2025

    Understand the growing trend of outsourcing regulatory affairs in pharma, driven by expanding R&D pipelines and the need for specialized expertise to manage product lifecycles effectively.

35. The Advantages Of Pharmacovigilance Outsourcing At The Local Level 4/14/2025

    Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.

36. Key Takeaways From PDA Ireland Microbiology Event On Innovation And Technology 4/14/2025

    Insights from a PDA Ireland event reveal how innovative technologies like VR and automation are transforming sterile manufacturing, improving efficiency and addressing contamination control strategies.

37. How Healthy Is Your TMF? A Check-In Before An Inspection 3/18/2025

    Explore how proper oversight of the Trial Master File (TMF) prevents inspection findings. Regular reviews, heatmaps, and risk-based assessments help ensure TMF health, and readiness for regulatory inspections.

38. Five Key Trends In CMC 3/18/2025

    CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.

39. Three Key Takeaways: Best Practices In Environmental Monitoring 3/18/2025

    An Environmental Monitoring (EM) program ensures microbial and particulate control in sterile manufacturing. A conference in India covered EM design, data interpretation, contamination risks, and regulatory expectations.

40. Effective Digital Engagement For Biopharma Companies 3/18/2025

    The NASP Podcast explores biopharma digital engagement, emphasizing strategic communication, data analytics, and best practices to enhance healthcare decision-maker engagement across a product’s lifecycle.